UPDATE: Jefferies Lowering Price Target on Savient Pharma

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Jefferies & Co. is out with a research report on Savient Pharma (NASDAQ: SVNT) and it is lowering its price target to $2 from $3, but is keeping its Hold rating on shares.In a note to clients, Jefferies & Co. writes, "Narrower 3Q11 net loss of ~$27M (vs. our net loss estimate of ~$32M) on non-cash income tax benefit; Krystexxa sales of ~$1.9M lower than our/cons estimates of $2.5M/$2.8M. Cash of ~$203M at end-3Q11 should be sufficient at least for next ~2 years. Lowering PT to $2 from $3 on a higher discount rate of 14% (12% previously) due to slower sales uptake."Shares of SVNT are off 1 cent to $3.56.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!